On Tuesday, Coherus Oncology Inc (NASDAQ: CHRS) opened higher 7.08% from the last session, before settling in for the closing price of $1.13. Price fluctuations for CHRS have ranged from $0.71 to $2.43 over the past 52 weeks.
It was noted that within the last five years, the titan of the Healthcare sector saw sales slided by -27.36%. Company’s average yearly earnings per share was noted -714.73% at the time writing. With a float of $102.19 million, this company’s outstanding shares have now reached $116.24 million.
Coherus Oncology Inc (CHRS) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Coherus Oncology Inc is 15.46%, while institutional ownership is 41.99%. The most recent insider transaction that took place on May 23 ’25, was worth 73,881. In this transaction Director of this company sold 99,988 shares at a rate of $0.74, taking the stock ownership to the 0 shares.
Coherus Oncology Inc (CHRS) Performance Highlights and Predictions
If we go through the results of last quarter, which was made public on 12/31/2024, the company posted -0.28 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -0.13) by -0.15. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.27 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -714.73% per share during the next fiscal year.
Coherus Oncology Inc (NASDAQ: CHRS) Trading Performance Indicators
Check out the current performance indicators for Coherus Oncology Inc (CHRS). In the past quarter, the stock posted a quick ratio of 1.23. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.75.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.59, a number that is poised to hit -0.34 in the next quarter and is forecasted to reach -1.00 in one year’s time.
Technical Analysis of Coherus Oncology Inc (CHRS)
The latest stats from [Coherus Oncology Inc, CHRS] show that its last 5-days average volume of 1.55 million was inferior to 1.57 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 16.82%.
During the past 100 days, Coherus Oncology Inc’s (CHRS) raw stochastic average was set at 41.88%, which indicates a significant increase from 17.39% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1279 in the past 14 days, which was higher than the 0.0927 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.5502, while its 200-day Moving Average is $1.1026. Now, the first resistance to watch is $1.2700. This is followed by the second major resistance level at $1.3300. The third major resistance level sits at $1.4150. If the price goes on to break the first support level at $1.1250, it is likely to go to the next support level at $1.0400. Assuming the price breaks the second support level, the third support level stands at $0.9800.
Coherus Oncology Inc (NASDAQ: CHRS) Key Stats
There are currently 120,871K shares outstanding in the company with a market cap of 146.25 million. Presently, the company’s annual sales total 266,960 K according to its annual income of 28,510 K. Last quarter, the company’s sales amounted to 11,570 K and its income totaled -35,530 K.
